*The 3-year first-time residency attainment rate is the weighted average of the 2022-23, through 2024-25 academic years. For each year, the rate is the percent of students attaining a residency out of all graduates or expected graduates in the year who were active applicants in the NRMP match in that year or who attained a residency outside the NRMP match in that year. The 1-year first-time residency attainment rate is 95% for 2024-2025 graduates.
Peter Chovanec, PhD
Associate Professor and Senior Lecturer in Molecular Cell Biology
Peter Chovanec, PhD, is an Associate Professor and Senior Lecturer in Molecular Cell Biology at the AUC School of Medicine's UK Track program. Dr. Chovanec is a faculty member at the University of Lancashire in Preston UK, where the program is delivered.
Dr. Peter Chovanec holds an MSc and PhD in biochemistry from the Slovak University of Technology in Bratislava, Slovakia. From 2002-2011, Dr. Chovanec conducted post-doctoral research at several large academic institutions, including Stockholm University in Sweden, the University of Manchester in the United Kingdom, and Duquesne University in the United States. His research, which focused on applying state-of-the-art technologies across a range of disciplines and involvement in several projects, has been widely published in international journals and textbooks.
Dr. Chovanec has served as fulltime faculty at international medical schools in the Caribbean, including the University of St. Eustatius School of Medicine in St. Eustatius, Saba University School of Medicine in Saba, and Medical University of the Americas in Nevis, West Indies.